Kaufman HL - Search Results

1

A new mouse model for evaluating the immunotherapy of human colorectal cancer.

Hörig H, Wainstein A, Long L, Kahn D, Soni S, Marcus A, Edelmann W, Kucherlapati R, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Cancer Res. 2001 Dec 1;61(23):8520-6. Cancer Res. 2001. PMID: 11731437

2

Current issues in cancer vaccine development.

Hörig H, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Clin Immunol. 1999 Sep;92(3):211-23. doi: 10.1006/clim.1999.4751. Clin Immunol. 1999. PMID: 10479526 Review. No abstract available.

3

A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma.

Kaufman HL, Conkright W, Divito J Jr, Hörig H, Kaleya R, Lee D, Mani S, Panicali D, Rajdev L, Ravikumar TS, Wise-Campbell S, Surhland MJ. Kaufman HL, et al. Hum Gene Ther. 2000 May 1;11(7):1065-82. doi: 10.1089/10430340050015374. Hum Gene Ther. 2000. PMID: 10811235 Clinical Trial. No abstract available.

4

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

Hörig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Cancer Immunol Immunother. 2000 Nov;49(9):504-14. doi: 10.1007/s002620000146. Cancer Immunol Immunother. 2000. PMID: 11092617 Free PMC article. Clinical Trial.

5

The next generation of vaccines for the treatment of cancer.

Long L, Glover RT, Kaufman HL. Long L, et al. Among authors: kaufman hl. Curr Opin Mol Ther. 1999 Feb;1(1):57-63. Curr Opin Mol Ther. 1999. PMID: 11249685 Review. No abstract available.

6

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.

Kicska GA, Long L, Hörig H, Fairchild C, Tyler PC, Furneaux RH, Schramm VL, Kaufman HL. Kicska GA, et al. Among authors: kaufman hl. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4593-8. doi: 10.1073/pnas.071050798. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287638 Free PMC article.

7

Innovative treatments for pancreatic cancer.

Lieberman SM, Hörig H, Kaufman HL. Lieberman SM, et al. Among authors: kaufman hl. Surg Clin North Am. 2001 Jun;81(3):715-39. doi: 10.1016/s0039-6109(05)70157-2. Surg Clin North Am. 2001. PMID: 11459285 Review.

8

A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.

Kaufman HL, DeRaffele G, Divito J, Hörig H, Lee D, Panicali D, Voulo M. Kaufman HL, et al. Hum Gene Ther. 2001 Jul 20;12(11):1459-80. doi: 10.1089/104303401750298616. Hum Gene Ther. 2001. PMID: 11485637 No abstract available.

9

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

Eppler E, Hörig H, Kaufman HL, Groscurth P, Filgueira L. Eppler E, et al. Among authors: kaufman hl. Eur J Cancer. 2002 Jan;38(1):184-93. doi: 10.1016/s0959-8049(01)00342-2. Eur J Cancer. 2002. PMID: 11750849

10

Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice.

Kaufman HL, Swartout BG, Hörig H, Lubensky I. Kaufman HL, et al. Cytokine. 2002 Jan 7;17(1):43-52. doi: 10.1006/cyto.2001.0986. Cytokine. 2002. PMID: 11886170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters